Evidence map›Paper›PMID 40278181›Full record

ReviewJournal of cardiovascular development and disease2025

Wearable Devices for Quantifying Atrial Fibrillation Burden: A Systematic Review and Bayesian Meta-Analysis.

Ioannis Anagnostopoulos, Dimitrios Vrachatis, Maria Kousta, Sotiria Giotaki, Dimitra Katsoulotou, Christos Karavasilis, Gerasimos Deftereos, Nikolaos Schizas, Dimitrios Avramides, Georgios Giannopoulos and 2 more

Abstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ioannis AnagnostopoulosDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.ORCID 0000-0002-3062-360X
Dimitrios VrachatisDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.ORCID 0000-0002-2385-5365
Maria KoustaDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.
Sotiria GiotakiDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.
Dimitra KatsoulotouCardiology Department, Athens General Hospital "G. Gennimatas", 11527 Athens, Greece.
Christos KaravasilisCardiology Department, Athens General Hospital "G. Gennimatas", 11527 Athens, Greece.
Gerasimos DeftereosDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.
Nikolaos SchizasDepartment of Cardiothoracic Surgery, Hygeia Hospital, 15123 Athens, Greece.ORCID 0000-0002-3523-4881
Dimitrios AvramidesCardiology Department, Athens General Hospital "G. Gennimatas", 11527 Athens, Greece.ORCID 0000-0002-0544-9160
Georgios Giannopoulos3rd Department of Cardiology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-7287-3850
Theodore G PapaioannouDepartment of Biomedical Engineering, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-1552-3168
Spyridon DeftereosDepartment of Interventional Cardiology and Electrophysiology, Evgenidio Hospital, 11528 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is the most common supraventricular arrhythmia and is associated with an impaired prognosis. Studies using implantable cardiac monitors suggest that this association is closely linked to AF burden, defined as the percentage of time spent in AF. Consequently, there is a growing need for affordable and comfortable alternative devices, such as wearables, capable of reliably monitoring AF burden in patients with AF.

methodsMajor electronic databases were searched for studies comparing AF burden quantification using wearables and reference ECG monitoring methods. A Bayesian approach was adopted for the final analysis.

resultsSix studies, including a total of 448 patients and 36,978 h of valid simultaneous recordings, were analyzed. Bayesian analysis revealed no statistically significant differences between wearables and reference methods in AF burden quantification. The mean error was 1% (95% CrIs: -4% to 7%). Similar findings were observed in the subgroup analysis of studies assessing only smartwatches. Between-study heterogeneity was low, and no evidence of publication bias was detected.

conclusionOur analysis suggests that AF burden quantification using wearables is comparable to reference ECG monitoring methods. These findings support the potential role of wearables in clinical practice, particularly for research and prognostic purposes. However, more studies are needed to determine whether the observed statistical equivalence translates to clinical significance, thereby supporting the widespread use of wearables in the assessment of rhythm control therapeutic strategies.

Indexed as

atrial fibrillationburdenprognosissmartwatcheswearables

Identifiers

PMID40278181
PMCPMC12028110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.